These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 340038)

  • 41. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
    Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ
    Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204
    [No Abstract]   [Full Text] [Related]  

  • 42. Phase II trial of vindesine in patients with malignant melanoma.
    Camacho FJ; Young CW; Wittes RE
    Cancer Treat Rep; 1980 Jan; 64(1):179-81. PubMed ID: 7379054
    [No Abstract]   [Full Text] [Related]  

  • 43. Phase II study of nafoxidine in the therapy for advanced renal carcinoma.
    Feun LG; Drelichman A; Singhakowinta A; Vaitkevicius VK; Oishi N
    Cancer Treat Rep; 1979 Jan; 63(1):149-50. PubMed ID: 369688
    [No Abstract]   [Full Text] [Related]  

  • 44. Phase II trial of 10-deazaaminopterin for advanced hypernephroma.
    Scher HI; Yagoda A; Ahmed T; Hollander P; Watson RC
    Anticancer Res; 1984; 4(6):409-10. PubMed ID: 6517533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
    Kris MG; Gralla RJ; Kalman LA; Kelsen DP; Casper ES; Burke MT; Groshen S; Cibas IR; Bagin R; Heelan RT
    Cancer Treat Rep; 1985 Apr; 69(4):387-95. PubMed ID: 3888388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of vindesine in patients with refractory small cell lung cancer.
    Chang AY; Witte RS; Tormey DC; Ramirez G
    Cancer Treat Rep; 1984 Nov; 68(11):1407-8. PubMed ID: 6094003
    [No Abstract]   [Full Text] [Related]  

  • 47. Recombinant interferon-alpha 2a and vinblastine in advanced renal cell cancer: a clinical phase I-II study.
    Kellokumpu-Lehtinen P; Nordman E
    J Biol Response Mod; 1990 Aug; 9(4):439-44. PubMed ID: 2395008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Piperazinedione in metastatic renal carcinoma.
    Pasmantier MW; Coleman M; Kennedy BJ; Eagan R; Carolla R; Weiss R; Leone L; Silver RT
    Cancer Treat Rep; 1977 Dec; 61(9):1731-2. PubMed ID: 340039
    [No Abstract]   [Full Text] [Related]  

  • 50. Phase II trial of 4'epi-adriamycin for advanced hypernephroma.
    Benedetto P; Ahmed T; Needles B; Watson RC; Yagoda A
    Am J Clin Oncol; 1983 Oct; 6(5):553-4. PubMed ID: 6577784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase II trial of vindesine in advanced neoplastic disease.
    Stambaugh JE
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():75-9. PubMed ID: 7438126
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of chronic myeloid leukemia blast crisis with vindesine and prednisone.
    Jehn U; Mezger J
    Cancer Treat Rep; 1985 Apr; 69(4):445-8. PubMed ID: 3857971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
    Osterlind K; Hørbov S; Dombernowsky P; Rørth M; Hansen HH
    Cancer Treat Rep; 1982 Feb; 66(2):305-9. PubMed ID: 7055816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP
    Cancer Treat Rep; 1982 Jul; 66(7):1585-6. PubMed ID: 7093973
    [No Abstract]   [Full Text] [Related]  

  • 55. [Phase II study of vindesine in patients with carcinoma of the lung and metastatic pulmonary tumor].
    Shibuya M; Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Shimabukuro Z
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1808-13. PubMed ID: 6307176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Therapy of the blast crisis in chronic myeloid leukemia. Results of a phase II study with vindesine].
    Hellriegel KP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):699-706. PubMed ID: 6172337
    [No Abstract]   [Full Text] [Related]  

  • 57. Vindesine in the treatment of esophageal carcinoma: a phase II study.
    Kelsen DP; Bains M; Cvitkovic E; Golbey R
    Cancer Treat Rep; 1979; 63(11-12):2019-21. PubMed ID: 526935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vindesine chemotherapy in lung cancer.
    Natale RB; Gralla RJ; Wittes RE; Golbey RB; Young CW
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():59-63. PubMed ID: 7438123
    [No Abstract]   [Full Text] [Related]  

  • 59. Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
    Gams RA; Nelson O; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):921-2. PubMed ID: 3521848
    [No Abstract]   [Full Text] [Related]  

  • 60. Vindesine: an effective agent in the treatment of non-small cell lung cancer.
    Furnas BE; Williams SD; Einhorn LH; Cobleigh MA
    Cancer Treat Rep; 1982 Sep; 66(9):1709-11. PubMed ID: 7116347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.